Back
News
1 min de lecture

[Press Release] XAV19 : validation of the first dose of anti-Covid treatment of XENOTHERA

  • contact@xenothera.com
  • Auteur
    contact@xenothera.com
  • Publié
    12 novembre 2020

Articles récents

[Press Alert] Safety and efficacy results of LIS1

June 2022. # Download our press information (english version) # Télécharger notre...

More

[Press Information] XENOTHERA presents LIS1 results at the American Transplant Congress (ATC) in Boston

May 2022. # Download our press information (english version) # Télécharger notre...

More

[ Press Information ] APPOINTMENTS

April 2022. # Download our press information (english version) # Télécharger notre...

More